Exchange: NASDAQ·Updated 07:57 PM EDT
KPTI logo

KPTI Karyopharm Therapeutics Inc

$0.605
$0.005
(0.83%)
Today
Closed $0.605
$0.005
(0.83%)
After Hours
EarningsNov 3
Mkt Cap$13.61M
Vol963,114.00

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A. Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008 and is headquartered in Newton, MA.
60

Bullish Sentiment

How do you feel about KPTI?

ekpemofolo
$KPTI I was staying away from Karyo for a long time. These are real hard times, because of immediate financing issues. But yesterday and today created a very attractive risk/reward situation. Not clear whether they will make it through the next weeks/months. But if they do, these days provide a great entry point. Big risk, but big reward. I am giving it a shot.
6
Carnagex
$KPTI I bought 25 more contracts Jan 2029 2.00 strike. Once the refinancing overhang clears then we are onto the science. Great entry imo. Time will tell.
1
3
ekpemofolo
$KPTI AI says that about 50% to 55% of distressed biotechs avoid default by either being bought out or via debt restructuring. Let's see whether we are in the lucky half.
1
1
Commenaudin36
$KPTI I just bought into KPTI at an average price of $0.67. This thing is a real gamble. You could lose everything, or you could see a 10x return. Do your research and you'll understand why. I'm taking the bet.
4
celebratelife
$KPTI RICHARD PAULSON, BARRY GREENE, GAREN BOHLIN... WASTED HUNDREDS OF MILLIONS IN INVESTOR MONEY ON THE FUCKING ENTITLED LAZY UNPRODUCTIVE VACATION-CLUB STYLE CULTURE AT SHAREHOLDER COST. THEY'VE NEVER GIVEN A SHIT ABOUT SHAREHOLDERS OR WASTING OUR MONEY AS LONG AS THEY GOT THEIR FUCKING BIG BUCKS DESPITE THEIR LOUSY PERFORMANCE. GREAT FOR INSIDERS, GREAT FOR SHORT SELLERS, GREAT FOR THEMSELVES AND THE REST OF THE LOUSY BOARD. DISASTER FOR SHAREHOLDERS. AND IT'S NOT LIKE HE DIDN'T KNOW. WE WARNED THEM TIME AND AGAIN BUT THEIR MIND WAS SOMEWHERE ELSE APPARENTLY -- NOT WHAT THEIR MANDATE CALLED FOR (TO DRIVE SHAREHOLDER VALUE) BUT TO MAXIMIZE THEIR OWN EXPERIENCE AT OUR COST. THAT'S HOW IT APPEARS. AND MEANWHILE SOME HEDGE FUNDS HAVE MADE HUNDREDS OF MILLIONS OF OUR MONEY.
1
1
Gius_me
$KPTI I still don’t understand why diluite and don’t declare bk…the only reason if they already have a buyout agreement with incyte if fda accepts snda or approve it
1
1
Biotech_Pharma_Investor
$KPTI $20M worth of preferred shares convertible into common stock at $1.62 granted to lenders just to allow KPTI to survive until October... doesnt look good
1
1
celebratelife
$KPTI February 28, 2020: Karyopharm announced Paulson's appointment to its board. March 2, 2020: KPTI reached approximately $27.72 per share, equivalent to $415.80 after the reverse split. October 8, 2026: KPTI traded as low as $0.60, equivalent to $0.04 before the reverse split. Decline: approximately 99.86% as the company under Richard Paulson burned through hundreds of millions of cash with no sense of accountability, responsibility, adherence to his mandate and the Board is every bit responsible for that. He ran the company like a fucking vacation club with no ethics to think runway, shareholder value, bottom line, financial discipline. Incompetent or compromised, is the question that will get answered.
2
celebratelife
$KPTI For years, the lousy, incompetent or compromised Richard Paulson/the Board of Directors led by Barry Greene that were supposed to control him, hurt the company financially in many ways including giving multi-six-figure donations and having lots of fun in celebrity photo shoots, and feeding their ugly faces with daily catered free lunches, and unnecessary travels, etc. etc. - everything good CEOs do NOT do. But they apparently never gave a shit about shareholders who hired them to create value. This picture shows they gave more money than Amgen! Hundreds of thousands of our money that they got by diluting us and toxic financing that paralyzed the company, with no fucking sense of ACCOUNTABILITY. And Paulson has the nerve after shit hit the fan to even utter the words "FINANCIAL DISCIPLINE".
3
Carnagex
$KPTI I’d think with the 20m in shares the lenders have skin in the game for a non-dilutive or partially non-dilutive restructure.
3
BluntForceOptions
$KPTI filed an 8-K today confirming a Forbearance Agreement and Limited Waiver across their term lenders, convertible noteholders, and royalty investors. Key takeaways from the filing: The default: Did not pay the ~$15.8M principal installment due yesterday (Sept 10). The runway: Creditors agreed to temporarily forbear until Oct 15, 2026 while the company negotiates restructuring, strategic alternatives, or an equity raise. The cost: Incurred a $20M forbearance fee paid via newly created 0% convertible preferred stock ($1.62 conversion price). Shares getting whacked this morning, down -18% to $1.33 on the headline. FWIW... this is why tracking bal sheet mechanics, debt covenants, and maturity dates matters just as much as clinical readouts. A filing catalyst buys attention; debt structure dictates survival. (For those following along, as noted on Sept 1, I stepped aside from my position for a small profit off the $1.80 entry to avoid holding through this exact binary.)
3
Commenaudin36
$KPTI I think that regarding $KPTI's price action today, we should be able to reach $0.71 or $0.72 to hit the upper bound of the bullish channel currently forming.
2
Commenaudin36
$KPTI Here are my bullish targets for $KPTI in the event of good news: 1st target: $1.50, 2nd target: $2.10, 3rd target: $6.50.
2
LQQKER_INSIDER
$KPTI Snd there's your sub $1.00. Now I'd wait for financing and hope for a direct placement before wading in.
2
Darth_Barrister
$KPTI Sorry, I am relatively new here so I am open to being told I am wrong, but the scenario you posed below is not the “only” reason they might dilute. They could dilute because they in fact do not have a partner lined up and they need to keep the lights on (and their salaries flowing) until they can find one.
2
profDB
$KPTI Its creditors agreed to temporarily hold off on enforcement, and the company has now issued $20 million of preferred stock as the fee for that arrangement. Helpful in the short term, but not a solution to its financial problems. approximately 12.35 million potential common shares…
2
Nickhzap
$KPTI this is getting interesting. Selenexor is still a reasonable drug. Decent sales. The market cap right now is pitiful. I’d consider a starter position if a financing deal is announced
2
BioGem
$KPTI I told everyone to sell but derided my post; you held on to hopes and dreams. The financials are destroyed and the BK press release is assured any day now. I am holding my short to zero.
1
24DV4NC3D
$KPTI ⚡️WHAT DID I SAY?!⚡️ DONT 💤 … ...💥🧨💥 >>>> >>>>> 🎯🎯🎯…. 🚀 >> EXTREME WILCARD >POTENTIAL >>> OVERSOLD TO THE MAX >>> GREAT SETUP! <<< >>>>>>> LISTEN! <<<<<<<<
1
QuantInsider
What's up with $KPTI? Up 21% over 5 days, nice squeeze action But here's the kicker, someone grabbed a big 3,374-contract Jan 2028 $0.50 put sweep at the ask after that $20M convertible preferred news That's a lot of downside protection being paid for, even with the rally Price is climbing, but those puts raise some serious caution If you're trading this, you might want to keep risks tight No wild bets here
1

Advertisement|Remove ads.